From: Comparative transcriptomics reveals similarities and differences between astrocytoma grades
Gene | Chromosome | Band | Expression | Tumor | Annotation |
---|---|---|---|---|---|
H3F3A | 1 | q42.12 | - | PA I | H3 histone, family 3A |
MEIS1 | 2 | p14 | - | PA I | Meis homeobox 1 |
NEUROD1 | 2 | q31.3 | - | PA I | neuronal differentiation 1 |
EOMES | 3 | p24.1 | - | PA I | eomesodermin |
ZIC1 | 3 | q24 | - | PA I | Zic family member 1 |
ZIC4 | 3 | q24 | - | PA I | Zic family member 4 |
EGR1 | 5 | q31.2 | + | PA I | early growth response 1 |
EN2 | 7 | q36.3 | - | PA I | engrailed homeobox 2 |
EGR3 | 8 | p21.3 | + | PA I | early growth response 3 |
CDKN2B | 9 | p21.3 | + | PA I | cyclin-dependent kinase inhibitor 2B (p15, inhibits CDK4) |
NTRK2 | 9 | q21.33 | + | PA I | neurotrophic tyrosine kinase, receptor, type 2 |
HIF1AN | 10 | q24.31 | + | PA I | hypoxia inducible factor 1, alpha subunit inhibitor |
SUV420H1 | 11 | q13.2 | - | PA I | suppressor of variegation 4-20 homolog 1 (Drosophila) |
KRAS | 12 | p12.1 | - | PA I | Kirsten rat sarcoma viral oncogene homolog |
ZIC2 | 13 | q32.3 | - | PA I | Zic family member 2 |
SUZ12 | 17 | q11.2 | - | PA I | SUZ12 polycomb repressive complex 2 subunit |
SUV420H2 | 19 | q13.42 | - | PA I | suppressor of variegation 4-20 homolog 2 (Drosophila) |
OLIG1 | 21 | q22.11 | + | PA I | oligodendrocyte transcription factor 1 |
OLIG2 | 21 | q22.11 | + | PA I | oligodendrocyte lineage transcription factor 2 |
ATRX | X | q21.1 | - | PA I | alpha thalassemia/mental retardation syndrome X-linked |
ZIC3 | X | q26.3 | - | PA I | Zic family member 3 |
FAM110C | 2 | p25.3 | - | AS II | family with sequence similarity 110, member C |
HEY2 | 6 | q22.31 | + | AS II | hes-related family bHLH transcription factor with YRPW motif 2 |
NR2E1 | 6 | q21 | - | AS II | nuclear receptor subfamily 2, group E, member 1 |
EYA1 | 8 | q13.3 | + | AS II | EYA transcriptional coactivator and phosphatase 1 |
GAS2 | 11 | p14.3 | - | AS II | growth arrest-specific 2 |
DLL3 | 19 | q13.2 | + | AS II | delta-like 3 (Drosophila) |
CDH4 | 20 | q13.33 | - | AS II | cadherin 4, type 1, R-cadherin (retinal) |
SHROOM2 | X | p22.2 | - | AS II | shroom family member 2 |
AP1AR | 4 | q25 | - | AS III | adaptor-related protein complex 1 associated regulatory protein |
CDC27 | 17 | q21.32 | - | AS III | cell division cycle 27 |
PPM1D | 17 | q23.2 | + | AS III | protein phosphatase, Mg2+/Mn2+ dependent, 1D |
ZNF24 | 18 | q12.2 | + | AS III | zinc finger protein 24 |
TXN2 | 22 | q12.3 | + | AS III | thioredoxin 2 |
AKT3 | 1 | q44 | - | GBM IV | v-akt murine thymoma viral oncogene homolog 3 |
MDM4 | 1 | q32.1 | + | GBM IV | MDM4, p53 regulator |
PDGFRB | 5 | q32 | + | GBM IV | platelet-derived growth factor receptor, beta polypeptide |
VEGFA | 6 | p21.1 | + | GBM IV | vascular endothelial growth factor A |
EGFR | 7 | p11.2 | + | GBM IV | epidermal growth factor receptor |
FGFR1 | 8 | p11.23 | + | GBM IV | fibroblast growth factor receptor 1 |
FGFR2 | 10 | q26.13 | - | GBM IV | fibroblast growth factor receptor 2 |
BIRC3 | 11 | q22.2 | + | GBM IV | baculoviral IAP repeat containing 3 |
ERRB2 | 14 | q24.3 | + | GBM IV | nuclear receptor |
NTRK3 | 15 | q25.3 | - | GBM IV | neurotrophic tyrosine kinase, receptor, type 3 |
BRCA1 | 17 | q21.31 | + | GBM IV | breast cancer 1, early onset |
AKT2 | 19 | q13.2 | + | GBM IV | v-akt murine thymoma viral oncogene homolog 2 |
SMARCA4 | 19 | p13.2 | + | GBM IV | SWI/SNF related, matrix associated, actin dependent regulator of chromatin |